Rare Diseases: Common Issues in Drug Development

This guidance addresses the following important aspects of drug development:  

  • Adequate description and understanding of the disease’s natural history
  • Adequate understanding of the pathophysiology of the disease and the drug’s proposed mechanism of action
  • Nonclinical pharmacotoxicology considerations to support the proposed clinical 36 investigation or investigation